Crohn's Disease Clinical Trials in Ogden, Utah

4 studies are recruiting for crohn's disease in Ogden, Utah right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

    Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 month…

    Stage
    Phase 4
    Ages
    18 to 80
    Site
    Advanced Research Institute, Ogden, Utah
    Locations
    101 in total
    Run by
    Takeda

    See if you can join NCT06581328 on ClinicalTrials.gov

  2. A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

    This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 3 active dose regimens of MORF-057 in adult study participants with moderately to severely active Crohn's disease (CD).

    Stage
    Phase 2
    Ages
    18 to 85
    Site
    Care Access Research - Ogden, Ogden, Utah
    Locations
    225 in total
    Run by
    Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

    See if you can join NCT06226883 on ClinicalTrials.gov

  3. Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

    Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting the bowels. It can cause many different symptoms including belly pain, diarrhea, tiredness, and weight loss. Treatments are available but do not work…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Care Access - Ogden /ID# 266428, Ogden, Utah
    Locations
    255 in total
    Run by
    AbbVie

    See if you can join NCT06548542 on ClinicalTrials.gov

  4. A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

    This is a phase 2b, randomized, double-blind, 3-arm study for the treatment of Crohn's disease. The primary objective of this study is to assess the efficacy of different doses of SAR442970 compared with placebo in participants with moderate to severe Crohn's disease. The total study duration is up…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Investigational Site Number: 8400016, Ogden, Utah
    Locations
    66 in total
    Run by
    Sanofi

    See if you can join NCT06958536 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.